Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGRONOMICS LIMITED Net Asset Value 2015

Nov 4, 2015

7474_rns_2015-11-04_58385cb3-4c16-4fc7-99e9-e80742e07e29.html

Net Asset Value

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4442E

Port Erin Biopharma Investments Ltd

04 November 2015

4 November 2015

Port Erin Biopharma Investments Limited

(the "Company")

Net Asset Value calculation to 30 September 2015

Jim Mellon, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 September 2015 was 10.04 pence per share, including un-invested cash of £67,542. The portfolio is valued under IFRS at bid price.

Net Assets stand at £2.3 million including Investments of £2.26 million. This quarter's NAV represents a decrease of 12.5% from the previous valuation of 11.47 pence per share, which included un-invested cash of £255,564. On this basis, no additional management fee is due to Shellbay Investments Limited.

The reported NAV to 30 September 2015 suffered due to some short-term share price fluctuations across the portfolio during the quarter.  The company's three principal investments continue to show significant growth potential for the remainder of 2015 and beyond".    

Unaudited to 30 September 2015    £
Fixed Assets
Investments 2,268,245
Current Assets
Sundry Debtors 17,230
Uninvested cash 67,542
Current Liabilities
Creditors: amounts due (24,185)
2,328,832
Capital and Reserves
Share Capital 23
Share Premium 1,890,142
Reserves 438,667
2,328,832
Shares in Issue 23,195,558
Net Asset Value per share 10.04 pence

Portfolio Details

Investments as at 30 September 2015 Value % of Total Portfolio
Magna Biopharma Income Fund £1,139,581 50.2%
Plethora Solutions Holdings £213,148 9.4%
Summit Corporation £417,264 18.4%
Other quoted holdings £254,920 11.2%
Other unquoted holdings £243,332 10.8%
Total £2,268,245 100.0%

For further information, please contact:

Port Erin Biopharma

Investments Limited
Beaumont Cornish Limited Peterhouse Capital Limited
The Company Nomad Broker
Denham Eke

(+44) (0) 1624 639396
Roland Cornish

(+44) (0) 207 628 3396
Lucy Williams

(+44) (0) 207 469 0936

This information is provided by RNS

The company news service from the London Stock Exchange

END

NAVFMMGMVFRGKZM